You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 9, March 5, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pharmacist Care for Reactive Airway Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Weinberger and colleagues1 found that patients with asthma who received pharmaceutical care experienced more breathing-related ED visits. It is possible that patients' interactions with the pharmacists resulted in constant reminder of the morbidity of uncontrolled asthma and resulted in a need to seek definitive treatment and further reassurance. The nature of the conversation with the pharmacist could have provided the patients with reinforcement of disease-related symptoms and increased reassurance of their own understanding of the disease. In any event, results suggest that patient-physician interaction may not be adequate to educate patients about chronic disease. Similar trends of improved care of heart failure management with the involvement of pharmacists have been previously reported.2

Despite physicians' best intentions, patients may delay in the initiation of therapy and may not gain adequate control of chronic symptoms. Such a phenomenon has been described as clinical inertia and results in suboptimal . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Pharmacist Care for Reactive Airway Disease
Ricky T. Guidry
JAMA. 2003;289(9):1103-1104.
EXTRACT | FULL TEXT  

Pharmacist Care for Reactive Airway Disease
John Jameson and Anthony J. Plas
JAMA. 2003;289(9):1104.
EXTRACT | FULL TEXT  

Pharmacist Care for Reactive Airway Disease
Martin Schulz
JAMA. 2003;289(9):1104.
EXTRACT | FULL TEXT  

Pharmacist Care for Reactive Airway Disease
John A. Gans and Jenna M. Williams
JAMA. 2003;289(9):1105.
EXTRACT | FULL TEXT  

Pharmacist Care for Reactive Airway Disease—Reply
Morris Weinberger, Michael D. Murray, and William M. Tierney
JAMA. 2003;289(9):1105-1106.
EXTRACT | FULL TEXT  

Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial
Morris Weinberger, Michael D. Murray, David G. Marrero, Nancy Brewer, Michael Lykens, Lisa E. Harris, Roopa Seshadri, Helena Caffrey, J. Franklin Roesner, Faye Smith, A. Jeffrey Newell, Joyce C. Collins, Clement J. McDonald, and William M. Tierney
JAMA. 2002;288(13):1594-1602.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.